Article
Blood lead levels, ALAD gene polymorphisms, and mortality.
Epidemiology (Cambridge, Mass.) - 1 Mar 2011
van Bemmel Dana M, Li Yan, McLean Jody, Chang Man-Huei, Dowling Nicole F, Graubard Barry, Rajaraman Preetha
Abstract excerpt
BACKGROUND: Previous analyses from the National Health and Nutrition Examination Survey (NHANES III) have found that elevated blood lead levels may be associated with cardiovascular mortality, cancer mortality, and all-cause mortality. The 5-aminolevulinic acid dehydratase (ALAD) G177C genetic polymorphism (rs 1800435) affects lead toxicokinetics and may alter the adverse effects of lead exposure. We examined...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
